Jordi Llop Roig-rekin lankidetzan egindako argitalpenak (6)

2021

  1. Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 226

2020

  1. An Assay for Screening Potential Drug Candidates for Alzheimer's Disease That Act as Chaperones of the Transthyretin and Amyloid-β Peptides Interaction

    Chemistry - A European Journal, Vol. 26, Núm. 72, pp. 17462-17469

  2. Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer's Disease Drug Discovery

    Journal of Medicinal Chemistry, Vol. 63, Núm. 6, pp. 3205-3214

  3. Oral Treatment with Iododiflunisal Delays Hippocampal Amyloid-β Formation in a Transgenic Mouse Model of Alzheimer's Disease: A Longitudinal in vivo Molecular Imaging Study

    Journal of Alzheimer's Disease, Vol. 77, Núm. 1, pp. 99-112

2019

  1. Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal

    Journal of Medicinal Chemistry, Vol. 60, Núm. 13, pp. 5749-5758